BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29224733)

  • 1. Validated MALDI-TOF-MS method for anthrax lethal factor provides early diagnosis and evaluation of therapeutics.
    Gallegos-Candela M; Boyer AE; Woolfitt AR; Brumlow J; Lins RC; Quinn CP; Hoffmaster AR; Meister G; Barr JR
    Anal Biochem; 2018 Feb; 543():97-107. PubMed ID: 29224733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures.
    Boyer AE; Gallegos-Candela M; Quinn CP; Woolfitt AR; Brumlow JO; Isbell K; Hoffmaster AR; Lins RC; Barr JR
    Anal Bioanal Chem; 2015 Apr; 407(10):2847-58. PubMed ID: 25673244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MALDI-TOF-MS and HPLC-ESI-MS/MS for endopeptidase activity-based quantification of Anthrax lethal factor in serum.
    Kuklenyik Z; Boyer AE; Lins R; Quinn CP; Gallegos-Candela M; Woolfitt A; Pirkle JL; Barr JR
    Anal Chem; 2011 Mar; 83(5):1760-5. PubMed ID: 21302970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.
    Lins RC; Boyer AE; Kuklenyik Z; Woolfitt AR; Goldstein J; Hoffmaster AR; Gallegos-Candela M; Leysath CE; Chen Z; Brumlow JO; Quinn CP; Bagarozzi DA; Leppla SH; Barr JR
    Anal Bioanal Chem; 2019 May; 411(12):2493-2509. PubMed ID: 30911800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and quantification of anthrax lethal factor in serum by mass spectrometry.
    Boyer AE; Quinn CP; Woolfitt AR; Pirkle JL; McWilliams LG; Stamey KL; Bagarozzi DA; Hart JC; Barr JR
    Anal Chem; 2007 Nov; 79(22):8463-70. PubMed ID: 17929949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.
    Solano MI; Woolfitt AR; Boyer AE; Lins RC; Isbell K; Gallegos-Candela M; Moura H; Pierce CL; Barr JR
    Analyst; 2019 Mar; 144(7):2264-2274. PubMed ID: 30810119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative mass spectrometry for bacterial protein toxins--a sensitive, specific, high-throughput tool for detection and diagnosis.
    Boyer AE; Gallegos-Candela M; Lins RC; Kuklenyik Z; Woolfitt A; Moura H; Kalb S; Quinn CP; Barr JR
    Molecules; 2011 Mar; 16(3):2391-413. PubMed ID: 21403598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization.
    Li H; Soroka SD; Taylor TH; Stamey KL; Stinson KW; Freeman AE; Abramson DR; Desai R; Cronin LX; Oxford JW; Caba J; Pleatman C; Pathak S; Schmidt DS; Semenova VA; Martin SK; Wilkins PP; Quinn CP
    J Immunol Methods; 2008 Apr; 333(1-2):89-106. PubMed ID: 18304568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthrax lethal factor inhibition.
    Shoop WL; Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Felcetto T; Michael BF; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Patel SB; Wisniewski D; Scapin G; Salowe SP; Zaller DM; Chapman KT; Scolnick EM; Schmatz DM; Bartizal K; MacCoss M; Hermes JD
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7958-63. PubMed ID: 15911756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent prospects toward therapeutics and diagnostics of anthrax.
    Chauhan R; Wadhwa G; Sharma SK; Jain CK
    Recent Pat Antiinfect Drug Discov; 2014; 9(1):52-61. PubMed ID: 25145329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass Spectrometric Detection of Bacterial Protein Toxins and Their Enzymatic Activity.
    Kalb SR; Boyer AE; Barr JR
    Toxins (Basel); 2015 Aug; 7(9):3497-511. PubMed ID: 26404376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of high-throughput assay of lethal factor using native substrate.
    Kim J; Choi MK; Koo BS; Yoon MY
    Anal Biochem; 2005 Jun; 341(1):33-9. PubMed ID: 15866525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthrax lethal factor inhibitors as potential countermeasure of the infection.
    Kumar BV; Malik S; Grandhi P; Dayam R; Sarma JA
    Curr Top Med Chem; 2014; 14(17):1977-89. PubMed ID: 25262802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated microfluidic enzyme reactor mass spectrometry platform for detection of anthrax lethal factor.
    Aravamudhan S; Joseph PJ; Kuklenyik Z; Boyer AE; Barr JR
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():1071-4. PubMed ID: 19965140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and use of a novel substrate for simple, rapid, and specific early detection of anthrax infection.
    Suryadi K; Shine N
    PLoS One; 2018; 13(11):e0207084. PubMed ID: 30412638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection.
    Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB
    J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anthrax protective antigen (PA) using europium labeled anti-PA monoclonal antibody and time-resolved fluorescence.
    Stoddard RA; Quinn CP; Schiffer JM; Boyer AE; Goldstein J; Bagarozzi DA; Soroka SD; Dauphin LA; Hoffmaster AR
    J Immunol Methods; 2014 Jun; 408():78-88. PubMed ID: 24857756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax toxin: a tripartite lethal combination.
    Ascenzi P; Visca P; Ippolito G; Spallarossa A; Bolognesi M; Montecucco C
    FEBS Lett; 2002 Nov; 531(3):384-8. PubMed ID: 12435580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.